Response-based Treatment of High-risk Neuroblastoma
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve outcome of high risk neuroblastoma by tailoring the
treatment intensity of tandem high dose chemotherapy according to the treatment response to
induction chemotherapy.